SunVax mRNA Therapeutics
- Biotech or pharma, therapeutic R&D
SunVax is a pioneering biotechnology company headquartered in the Greater Boston area, dedicated to revolutionizing the field of immunotherapy and vaccine development. Established in November 2021, SunVax has quickly emerged as a leader in the development of innovative therapeutic solutions, leveraging its proprietary state-of-the-art lipid nanoparticle (LNP) and self-amplifying mRNA (samRNA) platforms employing rigorous criteria to select the most potent and effective options. The company's strategic focus lies in harnessing the power of these advanced platforms to address critical unmet needs in various therapeutic areas, including immuno-oncology, infectious diseases, autoimmune diseases and rare diseases.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}